AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 282: H983-H989, 2002; doi:10.1152/ajpheart.00233.2001
0363-6135/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (33)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, Y. Y.
Right arrow Articles by Feldman, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Y. Y.
Right arrow Articles by Feldman, A. M.
Vol. 282, Issue 3, H983-H989, March 2002

MMP inhibition modulates TNF-alpha transgenic mouse phenotype early in the development of heart failure

Yun You Li, Toshiaki Kadokami, Ping Wang, Charles F. McTiernan, and Arthur M. Feldman

Cardiovascular Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213

Myocardial extracellular matrix remodeling regulated by matrix metalloproteinases (MMPs) is implicated in the progression of heart failure. We hypothesized that MMP inhibition may modulate extracellular matrix remodeling and prevent the progression of heart failure. The effects of the MMP inhibitor BB-94 (also known as batimastat) on MMP expression, collagen expression, collagen deposition, collagen denaturation, and left ventricular structure and function in transgenic mice with cardiac-restricted overexpression of tumor necrosis factor-alpha (TNF-alpha ) (TNF1.6) were assessed. The results showed that BB-94 reduced the expression of collagens, increased insoluble collagen and the ratio of undenatured to total soluble collagen, and prevented myocardial hypertrophy and diastolic dysfunction in young TNF1.6 mice. Furthermore, the treatment significantly improved cumulative survival of TNF1.6 mice. However, MMP inhibition did not have salutary effects on ventricular size and function in old mice with established heart failure. The results suggest that MMP activation may play a critical role in changes of myocardial function through the remodeling of extracellular matrix, and MMP inhibition may serve as a potential therapeutic strategy for heart failure, albeit within a narrow window during the development of heart failure.

metalloendopeptidases; ventricular remodeling; extracellular matrix; collagen


This article has been cited by other articles:


Home page
 Physiol. Rev.Home page
F. G. Spinale
Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function
Physiol Rev, October 1, 2007; 87(4): 1285 - 1342.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
H. Matsusaka, M. Ikeuchi, S. Matsushima, T. Ide, T. Kubota, A. M. Feldman, A. Takeshita, K. Sunagawa, and H. Tsutsui
Selective disruption of MMP-2 gene exacerbates myocardial inflammation and dysfunction in mice with cytokine-induced cardiomyopathy
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1858 - H1864.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
D. Gurantz, A. Yndestad, B. Halvorsen, O. V. Lunde, J. H. Omens, T. Ueland, P. Aukrust, C. D. Moore, J. Kjekshus, and B. H. Greenberg
Etanercept or intravenous immunoglobulin attenuates expression of genes involved in post-myocardial infarction remodeling
Cardiovasc Res, July 1, 2005; 67(1): 106 - 115.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
M. Brown, M. McGuinness, T. Wright, X. Ren, Y. Wang, G. P. Boivin, H. Hahn, A. M. Feldman, and W. K. Jones
Cardiac-specific blockade of NF-{kappa}B in cardiac pathophysiology: differences between acute and chronic stimuli in vivo
Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H466 - H476.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
N. Kawamura, T. Kubota, S. Kawano, Y. Monden, A. M. Feldman, H. Tsutsui, A. Takeshita, and K. Sunagawa
Blockade of NF-{kappa}B improves cardiac function and survival without affecting inflammation in TNF-{alpha}-induced cardiomyopathy
Cardiovasc Res, June 1, 2005; 66(3): 520 - 529.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
V. Polyakova, S. Hein, S. Kostin, T. Ziegelhoeffer, and J. Schaper
Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression
J. Am. Coll. Cardiol., October 19, 2004; 44(8): 1609 - 1618.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
S. Meiners, B. Hocher, A. Weller, M. Laule, V. Stangl, C. Guenther, M. Godes, A. Mrozikiewicz, G. Baumann, and K. Stangl
Downregulation of Matrix Metalloproteinases and Collagens and Suppression of Cardiac Fibrosis by Inhibition of the Proteasome
Hypertension, October 1, 2004; 44(4): 471 - 477.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. Engel, R. Peshock, R. C. Armstong, N. Sivasubramanian, and D. L. Mann
Cardiac myocyte apoptosis provokes adverse cardiac remodeling in transgenic mice with targeted TNF overexpression
Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1303 - H1311.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. Diwan, Z. Dibbs, S. Nemoto, G. DeFreitas, B. A. Carabello, N. Sivasubramanian, E. M. Wilson, F. G. Spinale, and D. L. Mann
Targeted Overexpression of Noncleavable and Secreted Forms of Tumor Necrosis Factor Provokes Disparate Cardiac Phenotypes
Circulation, January 20, 2004; 109(2): 262 - 268.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Herget, J. Novotna, J. Bibova, V. Povysilova, M. Vankova, and V. Hampl
Metalloproteinase inhibition by Batimastat attenuates pulmonary hypertension in chronically hypoxic rats
Am J Physiol Lung Cell Mol Physiol, July 1, 2003; 285(1): L199 - L208.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
B. S. McGowan, C. B. Scott, A. Mu, R. J. McCormick, D. P. Thomas, and K. B. Margulies
Unloading-induced remodeling in the normal and hypertrophic left ventricle
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2061 - H2068.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
W. Briest, A. Holzl, B. Rassler, A. Deten, H. A Baba, and H.-G. Zimmer
Significance of matrix metalloproteinases in norepinephrine-induced remodelling of rat hearts
Cardiovasc Res, February 1, 2003; 57(2): 379 - 387.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
M. Pauschinger, K. Chandrasekharan, J. Li, W. Poller, M. Noutsias, C. Tschope, and H.-P. Schultheiss
Inflammation and extracellular matrix protein metabolism: two sides of myocardial remodelling
Eur. Heart J. Suppl., December 1, 2002; 4(suppl_I): I49 - I53.
[Abstract] [PDF]

Home page
 Mol. Interv.Home page
B. J. Holycross and M. J. Radin
Cytokines in Heart Failure: Potential Interactions with Angiotensin II and Leptin
Mol. Interv., November 1, 2002; 2(7): 424 - 427.
[Abstract] [Full Text]

Home page
 Eur. J. Cardiothorac. Surg.Home page
V. Falk, P.M. Soccal, J. Grunenfelder, G. Hoyt, T. Walther, and R.C. Robbins
Regulation of matrix metalloproteinases and effect of MMP-inhibition in heart transplant related reperfusion injury
Eur. J. Cardiothorac. Surg., July 1, 2002; 22(1): 53 - 58.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online